Therapy in cancer 2008 quo vadis?
| Main Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
London
Henry Stewart Talks
2009, 2009
|
| Series: | Cancer therapy : latest thinking in efficacy and toxicity
|
| Subjects: | |
| Online Access: | |
| Collection: | Henry Stewart Talks - Collection details see MPG.ReNa |
Table of Contents:
- Why pursuing new therapeutic approaches in cancer is important
- Prevention and screening
- Current cancer therapy: non-surgical
- Most chemotherapy targets DNA
- Chemotherapy effects
- Current state of cancer therapy: efficacy and toxicity
- Molecular pathogenesis of cancer
- Pursuing targeted therapy in cancers
- Targeted biologic therapies
- Evolving targets and agents
- Shift from chemotherapy to targeted agents
- Clinically established molecular targets in malignancies
- Targeted therapy: proteins and small molecules
- Changes brought about by targeting: efficacy and toxicity
- Biomarkers in drug development
- What is currently known: angiogenesis
- The VEGF family and its receptors
- Bevacizumab and Sorafenib
- Does toxicity correlate with response?
- What research is ongoing: agents?
- Future directions in cancer treatment options
- Core pathways altered in pancreatic and colorectal cancer